Single embryo transfer (SET) and comprehensive chromosome screening (CCS) can result in equivalent delivery rates, healthier babies, and lower costs, according to research presented at the 69th Annual meeting of the American Society for Reproductive Medicine.
Investigators from Reproductive Medicine Associates of New Jersey looked at a subset (n = 25) of patients who had participated in an earlier clinical trial of blastocyst euploid selective transfer. The trial compared successful pregnancy rates between women who had undergone SET with CCS and those who had undergone double embryo transfer (DET).
A review of the subset showed that 0% of the women who had undergone SET plus CCS had multiples, while 48% of women with DET had. The incidence of low birth weight was reduced to 4.4% for SET and 34.8% for DET, and preterm delivery to 8.9% (SET) and 28.3% (DET).
Risk of a neonatal intensive care unit (NICU) admission was 11% in the SET-plus-CCS group versus 26% in the DET group, and the average NICU stay was significantly shorter in the SET-plus-CCS group (8 days) compared to the DET group (25 days).
Women who underwent DET were found to spend nearly $20,000 more in total delivery costs than women who underwent SET plus CCS. While SET plus CCS was associated with higher laboratory procedure costs ($21,475 vs $16,533), average total charges through 28 days post-delivery were significantly lower among SET plus CCS patients ($49,269) than in DET patients ($73,607).
Forman EJ, Hong KH, Werner MD, Singer SA, Benson MR, Scott RT Jr. Reducing the burden of ART care: single blastocyst transfer after comprehensive chromosome screening (CCS) provides equivalent delivery rates, eliminates twins and lowers global health care costs. Fertil Steril. 2013;100(3):S43.
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More